Financial Information

Tax Information Letter    Form 10 Information Statement

Myriad Genetics, Inc.'s latest financial information is provided below. We are a July 1 to June 30 fiscal year company.

Latest Earnings Release and 10-Q Date Filed Format Size  
Second Quarter Financial Results HTML file N/A  
Form 10-Q Feb 1, 2012 HTML file  PDF file 298.2 KB Add to Briefcase
Form 10-Q Nov 2, 2011 HTML file  PDF file 272.6 KB Add to Briefcase
 
Latest Annual Report and 10-K Date Filed Format Size  
Annual Report 2011   PDF 425.1 KB Add to Briefcase
Form 10-K Aug 15, 2011 HTML file  PDF file 1.2 MB Add to Briefcase
 
Latest Proxy Statement Date Filed Format Size  
Proxy Statement (DEFA14A) Oct 11, 2011 HTML file   PDF file 52.8 KB Add to Briefcase
Proxy Statement Oct 11, 2011 HTML file   PDF file 641.9 KB Add to Briefcase
Add to Briefcase = add file to Briefcase

Stock transaction information provided by EDGAR Online. Myriad Genetics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.













Stock Information
Ticker:MYGN
Exchange: NASDAQ
Last Trade: $23.84
Change: up 0.18
Volume: 616,300

Feb 3, 2012  4:00 PM ET
Quotes delayed at least 20 minutes. Information provided by eSignal.

Contact
Rebecca Chambers
Director, Investor Relations
801-584-1143
rchamber@myriad.com